Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-05

FDA Approved: TOPIRAMATE — Original Application (Vitruvias Therapeutics, Inc.)

View source ↗

Summary

FDA approves Vitruvias Therapeutics' generic Topiramate through an Original Application (ANDA), expanding access as a generic option for epilepsy and migraine p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

ORIG AP for TOPIRAMATE (TOPIRAMATE)